ATRS Antares Pharma Inc.

$2.32 +5.46%

736,242 Shares Traded
1,324,057 Average Volume (last 30 days)

as of 2:45:25 PM EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $476.45 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-6.28%
If Intiated One Month Ago, Shorts Have Realized a Return of:2.22%
If Initiated Five Days ago, Shorts Have Realized a Return of:6.38%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 2.86%
Short Interest3.97 million
Float139.01 million
Short Ratio4.29
Market Cap$344.68 million
Market Maker ActivityDaily Short Volume


Biotech Forum Daily Digest For January 16th (SeekingAlpha)
Midday Gainers / Losers (2/15/2018) (SeekingAlpha)
Premarket Gainers as of 9:05 am (02/15/2018) (SeekingAlpha)
FDA OKs AMAG Pharma's Makena subcutaneous auto-injector; shares up 16% premarket (SeekingAlpha)
Biotech Forum Daily Digest For February 12th (SeekingAlpha)
U.S. Biotech/Pharma Sector Daily Observations Letter: January 16, 2018 (SeekingAlpha)
Biotech Daily Digest For January 16th (SeekingAlpha)
Ad Com next week for Clarus Therapeutics' oral testosterone (SeekingAlpha)
3 Biotechs For The January Effect (SeekingAlpha)
ATRS Reminder Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit against Antares Pharma, Inc. (Business Wire)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 37.5%

Earnings Stats

PE Ratio -21.09
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.58
50 Day Moving Average $2.12
52 Week High $4.09
52 Week Low $1.58

Data provided for free by IEX. Questions? Read the FAQ